Potential of tyrosine kinase receptor TIE-1 as novel therapeutic target in high-PI3K-expressing ovarian cancer
10.3390/cancers12061705
Saved in:
Main Authors: | Zhang, X., Ishibashi, M., Kitatani, K., Shigeta, S., Tokunaga, H., Toyoshima, M., Shimada, M., Yaegashi, N. |
---|---|
Other Authors: | CANCER SCIENCE INSTITUTE OF SINGAPORE |
Format: | Article |
Published: |
MDPI AG
2021
|
Subjects: | |
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/197727 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Potent therapeutic activity of folate receptor-targeted liposomal carboplatin in the localized treatment of intraperitoneally grown human ovarian tumor xenograft
by: Chaudhury, A., et al.
Published: (2014) -
Ovarian Cancer
Published: (2017) -
Use of hormone replacement therapy before and after ovarian cancer diagnosis, and ovarian cancer survival
by: Mascarenhas, C., et al.
Published: (2015) -
Molecular mechanisms of tumor resistance to PI3K-mTOR-targeted therapy
by: Tan, J., et al.
Published: (2014) -
FOLATE RECEPTOR TARGETED LIPOSOMES AS THE ENABLING TECHNOLOGY FOR THE DELIVERY OF CHEMOTHERAPEUTICS IN THE TREATMENT OF OVARIAN CANCER
by: ANUMITA CHAUDHURY
Published: (2012)